Literature DB >> 19201824

Involvement of TLR2 in innate response to Bacillus anthracis infection.

Shay Weiss1, Haim Levy, Morly Fisher, David Kobiler, Zeev Altboum.   

Abstract

The involvement of TLR2 receptor in the innate response to infection with Bacillus anthracis was investigated. We studied the response to virulent or attenuated Vollum strains in either in vitro assays using macrophage cultures, or in an in vivo model comparing the sensitivity of Syrian hamster cells (expressing normal TLR2) to Chinese hamster cells (lacking functional TLR2) to infection by the various B. anthracis strains. Phagocytosis experiments with murine cell cultures or primary macrophages from both hamster strains, using virulent or attenuated Tox(+)Cap(-), Tox(-)Cap(+) or Tox(-)Cap(-) spores indicated that the secretion of TNF-alpha was induced by all the bacterial spores and purified spore antigens. In contrast, capsular antigens induce secretion of TNF-alpha only by Syrian hamster macrophages indicating the involvement of a functional TLR2 in macrophage activation. Challenge experiments with both hamster strains by intranasal spore inoculation, indicated that, while both strains are equally sensitive to infection with the virulent strain, the Chinese hamster demonstrated a higher sensitivity to infection with the toxinogenic or encapsulated strains. In conclusion, our findings imply that TLR2 has an important role in the attempt of the innate immunity to control B. anthracis infection, although TNF-alpha secretion was found to be mediated by both TLR2-dependent and TLR2-independent pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19201824     DOI: 10.1177/1753425908100379

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  5 in total

1.  Human Innate Immune Cells Respond Differentially to Poly-γ-Glutamic Acid Polymers from Bacillus anthracis and Nonpathogenic Bacillus Species.

Authors:  Tanya M Jelacic; Wilson J Ribot; Jennifer Chua; Anne E Boyer; Adrian R Woolfitt; John R Barr; Arthur M Friedlander
Journal:  J Immunol       Date:  2020-01-13       Impact factor: 5.422

2.  The Poly-γ-d-Glutamic Acid Capsule Surrogate of the Bacillus anthracis Capsule Is a Novel Toll-Like Receptor 2 Agonist.

Authors:  Jun Ho Jeon; Hae-Ri Lee; Min-Hee Cho; Ok-Kyu Park; Jungchan Park; Gi-eun Rhie
Journal:  Infect Immun       Date:  2015-07-20       Impact factor: 3.441

3.  Exposure to Bacillus anthracis capsule results in suppression of human monocyte-derived dendritic cells.

Authors:  Tanya M Jelacic; Donald J Chabot; Joel A Bozue; Steven A Tobery; Michael W West; Krishna Moody; De Yang; Joost J Oppenheim; Arthur M Friedlander
Journal:  Infect Immun       Date:  2014-06-02       Impact factor: 3.441

4.  Bacillus anthracis genomic DNA enhances lethal toxin-induced cytotoxicity through TNF-α production.

Authors:  Jun Ho Jeon; Yeon Hee Kim; Min Kyung Choi; Kyung Ae Kim; Hae-Ri Lee; Jeyoun Jang; Yu-Ri Kim; Jeong-Hoon Chun; Seong Kug Eo; Tae Sung Kim; Gi-Eun Rhie
Journal:  BMC Microbiol       Date:  2014-12-04       Impact factor: 3.605

5.  Next-Generation Bacillus anthracis Live Attenuated Spore Vaccine Based on the htrA(-) (High Temperature Requirement A) Sterne Strain.

Authors:  Theodor Chitlaru; Ma'ayan Israeli; Erez Bar-Haim; Uri Elia; Shahar Rotem; Sharon Ehrlich; Ofer Cohen; Avigdor Shafferman
Journal:  Sci Rep       Date:  2016-01-06       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.